FOXK2 and breast carcinoma: Chemotherapy is essential for improving outcomes (eg preventing or decreasing recurrence, progression and metastasis) in patients with cancer,14, 15, 16, 17 and FOXK2 has been shown to reduce the chemosensitivity of paclitaxel in breast cancer cells.18